NewGenIvf Group Ltd (NIVF)

NASD · Healthcare · Medical Care Facilities · Thailand

NewGenIvf Group Ltd is a micro cap company (market value under $300 million) in the Medical Care Facilities industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the NewGenIvf Group Ltd stock.

Our verdict on NIVF

Undervalued: intrinsic value $0.57 per share, market price $0.17, margin of safety 70.1% (as of 2026-11-17).

Its through-the-cycle earnings (0.8% median margin), capitalised at 6.0% with no growth, values the shares at $0.57; the price of $0.17 is 70% below that value.

More on NIVF

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Cheaper than NIVF in Medical Care Facilities

Is NIVF undervalued or overvalued?

NIVF is undervalued (as of the 2026-11-17 close). Its through-the-cycle earnings (0.8% median margin), capitalised at 6.0% with no growth, values the shares at $0.57; the price of $0.17 is 70% below that value.

What is the intrinsic value of NIVF?

$0.57 per share (as of the 2026-11-17 close), against a market price of $0.17. That is a margin of safety of 70.1%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.